The peripheral zone of the prostate is more prone to tumor development than the transitional zone: is the ETS family the key?

Predisposition to develop prostate cancer (PCA) varies among the prostate zones, with the peripheral zone (PZ) more prone to tumor development than the transitional zone (TZ). In view of the fact that molecular differences between the zones may explain this difference, combined with the findings that translocations between TMPRSS2 and several ETS members are frequently observed in PCA, we hypothesized that the ETS family may be crucial to explaining this difference. Normal tissues from the PZ and the TZ of 20 PCA patients were laser microdissected to separate glands from stroma. Two oligo microarrays were performed in order to investigate the variation in ETS family gene expression between the glands and the stroma of the two zones. The ETS members, ELF-3, ELF-5, ERG, ETV-1, ETV-4, ETV-5, ETV-7 and FEV, were found to be differentially expressed. A striking observation was that ERG and ETV-1 were found to be up-regulated in the glands of the PZ compared to the TZ, particularly when considering that ERG and ETV-1 fusions account for 50-80% and 20% of PCA occurrences, respectively. These results indicate that the glands and stroma of the two zones display distinct molecular differences and zonal-specific expression of ETS members. Furthermore, ETS members up-regulated in PCA are already overexpressed in the normal PZ, suggesting that these members play a role in the development and progression of PCA.

[1]  J. McNeal The zonal anatomy of the prostate , 1981, The Prostate.

[2]  S-H Tan,et al.  ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification , 2010, Prostate Cancer and Prostatic Diseases.

[3]  A. Wellmann,et al.  Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts. , 2006, International journal of molecular medicine.

[4]  W. Isaacs,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Pathological and Molecular Aspects of Prostate Cancer Prostate Cancer Ii , 2022 .

[5]  G. Thomas,et al.  A new member of the ETS family fused to EWS in Ewing tumors , 1997, Oncogene.

[6]  J. Martínez-Peñuela,et al.  [Primary adenocarcinoma of the seminal vesicles]. , 2009, Archivos espanoles de urologia.

[7]  Peter Albers,et al.  Analysis of microdissected prostate tissue with ProteinChip arrays--a way to new insights into carcinogenesis and to diagnostic tools. , 2002, International journal of molecular medicine.

[8]  Y. Ko,et al.  Influence of histochemical stains on quantitative gene expression analysis after laser-assisted microdissection. , 2003, International journal of molecular medicine.

[9]  J. Tchinda,et al.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.

[10]  R. Buettner,et al.  Differential expression of ETS family members in prostate cancer tissues and androgen-sensitive and insensitive prostate cancer cell lines. , 2011, International journal of molecular medicine.

[11]  S. Dhanasekaran,et al.  Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer , 2007, Nature.

[12]  V. Findlay,et al.  ETS Transcription Factor Expression and Conversion During Prostate and Breast Cancer Progression , 2010 .

[13]  Jin He,et al.  Profile of Ets gene expression in human breast carcinoma , 2007, Cancer biology & therapy.

[14]  N. Ragavan,et al.  Gene expression profiling of the human prostate zones , 2006, BJU international.

[15]  B. Czerniak,et al.  Prostate cancer of transition zone origin lacks TMPRSS2–ERG gene fusion , 2009, Modern Pathology.

[16]  L. Chung,et al.  Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting. , 2002, Differentiation; research in biological diversity.

[17]  M. Roncalli,et al.  Molecular disorders in transitional vs. peripheral zone prostate adenocarcinoma , 2001, International journal of cancer.

[18]  Nicolas Wernert,et al.  Laser-assisted microdissection, techniques and applications in pathology (review). , 2005, International journal of molecular medicine.

[19]  J. Wang-Rodriguez,et al.  In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Hayward,et al.  Role of stroma in carcinogenesis of the prostate. , 2002, Differentiation; research in biological diversity.

[21]  G. Cunha Role of mesenchymal‐epithelial interactions in normal and abnormal development of the mammary gland and prostate , 1994, Cancer.

[22]  A. Chinnaiyan,et al.  Recurrent gene fusions in prostate cancer , 2008, Nature Reviews Cancer.

[23]  A. Freeman,et al.  Comparison of the zones of the human prostate with the seminal vesicle: Morphology, immunohistochemistry, and cell kinetics , 2005, The Prostate.

[24]  S. Dhanasekaran,et al.  ETS rearrangements and prostate cancer initiation , 2009, Nature.

[25]  Lang Li,et al.  Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate , 2004, Cancer.

[26]  T. Stamey,et al.  Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.

[27]  J. Baert,et al.  ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion. , 2007, Molecular endocrinology.

[28]  D J Ruiter,et al.  HISTOLOGICAL GRADE HETEROGENEITY IN MULTIFOCAL PROSTATE CANCER. BIOLOGICAL AND CLINICAL IMPLICATIONS , 1996, The Journal of pathology.